Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Tumor Response Rate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1268 Neoplasms 878 Colorectal Neoplasms 726 Carcinoma, Non-Small-Cell Lung 640 Carcinoma, Hepatocellular 615 Stomach Neoplasms 569 Lung Neoplasms 513 Prostatic Neoplasms 479 Pancreatic Neoplasms 397 Rectal Neoplasms 288 Neoplasm Metastasis 263 Uterine Cervical Neoplasms 257 Recurrence 256 Colonic Neoplasms 252 Ovarian Neoplasms 250 Esophageal Neoplasms 234 Leukemia, Myeloid, Acute 226 Head and Neck Neoplasms 214 Multiple Myeloma 208 Brain Neoplasms 187 Nasopharyngeal Carcinoma 181 Melanoma 180 Polycystic Ovary Syndrome 175 Urinary Bladder Neoplasms 171 Precursor Cell Lymphoblastic Leukemia-Lymphoma 164 Liver Neoplasms 154 Lymphoma 151 Endometrial Neoplasms 137 Lymphoma, Large B-Cell, Diffuse 126 Glioma 125

Interventions

Sirtuins 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡